Clinical trial Recruiting at 1 site Interventional Ages 18 to 90

Effects of excitatory and inhibitory LIFUS of GPi in Parkinson’s patients without DBS

Official title: Effects of Excitatory and Inhibitory LIFUS of GPi in Parkinsonian Patients Without DBS

Run by University Health Network, Toronto · NCT07846007 · Data updated 2026-11-12

This study tests two deep-brain focused ultrasound patterns on people with Parkinson’s to see if they change task performance and tremor, compared with a sham stimulation.

More Parkinson Disease (PD) trials

Quick facts

Study typeInterventional
Ages18 Years to 90 Years
SexAll
Enrollment15 (estimated)
SponsorUniversity Health Network, Toronto
Academic / other
Locations1 site (Toronto, Ontario)
StatusRecruiting
StartedFebruary 14, 2024
Main results expectedDecember 2027
Study endsDecember 2028
Registry record updatedSeptember 29, 2026
Trial IDNCT07846007 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–90 with a confirmed Parkinson’s disease diagnosis, on a stable dopaminergic regimen for at least 4 weeks.

Probably not a fit

Individuals with a history of stroke or seizure, cognitive impairment (MoCA < 22), intracranial implants, implanted pacemakers/ICDs, prior movement disorder surgeries, or contraindicating metal implants may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will apply two deep brain stimulation-like ultrasound protocols to the GPi region in people with Parkinson’s disease, in random sessions with a sham comparison. Participants undergo baseline MRI, followed by three visits where different LIFUS patterns are delivered and tasks are performed, including a stop-signal task, UPDRS motor scoring, and finger tremor measurements. The study compares theta-burst and 10 Hz inhibitory stimulation against a sham condition to understand how these protocols may influence motor control and tremor. Outcomes include behavioral performance, motor scores, and tremor metrics to explore potential mechanisms and efficacy.

Why it matters

Potential benefit: If successful, participants could experience improvements in motor control and tremor and gain insight into non-invasive brain stimulation approaches for PD.

How similar studies have gone: Prior work on non-invasive brain stimulation has shown mixed results; this trial explores novel deep-brain LIFUS targets and protocols in PD, which is relatively new but builds on related neuromodulation approaches.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 18-90 years of age
* Confirmed diagnosis of Parkinson's disease
* Stable dopaminergic medication dose for a minimum of 4 weeks

Exclusion Criteria:

* History of stroke or seizure
* Comorbid dementia
* Scored below 22 on the Montreal Cognitive Assessment (MoCA)
* Has intracranial implant(s) or device(s)
* Has an implanted cardiac pacemaker or implantable cardioverter-defibrillator (ICD)
* Has a previous surgical intervention to treat the movement disorder such as lesioning or a Deep Brain Stimulation system in place.
* Presence of metal implanted in body that is contraindicated in TMS/MRI/peripheral electrical stimulation
* Pregnancy
* Major depression/psychiatric disorder that in the opinion of the Investigator will affect patient's understanding of study procedures and willingness to abide by all procedures during the course of the study
* Is on antipsychotics, anti-depressants, marijuana, or other recreational drugs that affect the nervous system
* Major musculoskeletal or neuromuscular disease or disorder of the hands, wrists and limbs
* Severe Dyskinesia
* Major systemic illness or infection

Where it's running

  • Toronto Western Hospital
    Toronto, Ontario, Canada
    Recruiting

Study contacts

  • Principal investigator: Robert Chen, MBBS — University Health Network, Toronto
  • Study coordinator: Julian Kwok
  • Email: julian.kwok@uhn.ca
  • Phone: 416-603-5800

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.